FAQ
Locate A Certified Provider Near You

Introducing

Ultherapy Prime

EMBRACE YOUR NEW PRIME WITH ULTHERAPY PRIME

THE ADVANCED, NON-INVASIVE LIFT
HYPER-PERSONALISED TO YOUR Uniqueness

Ultherapy PRIME is the next-generation micro-focused ultrasound treatment for skin lifting and tightening, and the only U.S. FDA-cleared1-3 procedure with real-time visualisation that enables aesthetic physicians to directly see different anatomical layers of the skin they are treating to deliver safe, precise4 and optimal results.

THE PRIME

Difference

Our most sophisticated and comprehensive upgrade yet. Our unique approach helps lift and tighten skin with minimal to no downtime, ensuring natural-looking results over 90 days.

TRUST IN ULTHERAPY PRIME® FOR A HYPER-PERSONALISED TREATMENT
THAT ELEVATES YOUR SKIN TO ITS Prime
  • FASTER REFRESH RATE FOR STABLE AND CLEAR IMAGING

    • Ensures accurate assessment of skin anatomy in real-time for personalised treatment • Allows effective targeting of desired skin layers

  • 35% LARGER SCREEN

    • Clearer and more detailed imagery of skin for safer treatment • Ensures optimal coupling with the skin • Allows patients to see and understand the uniqueness of their skin

Ultherapy Prime technology
  • 2X LARGER VISUALISATION FIELD

    • Clearer and more detailed imagery of skin for more personalised, effective, and comfortable treatment • Allows precision to safely avoid bones, nerves, and blood vessels and reduce patient discomfort • Enables aesthetic physicians to see at any angle

  • 10X FASTER PROCESSING PERFORMANCE

    • Allows for 20% faster treatment time

  • QUIET SYSTEM SOUNDS

    • For a better treatment experience

1. Ulthera Instruction for use
2. Ulthera release: Ultherapy® décolletage treatment now FDA-cleared. BioSpace website.https://www.biospace.com/
3. Article/releases/ulthera-release-ultherapy-and-0174-d%C3%A9colletage-treatment-now-fda-cleared-/. Accessed January 21, 2020.
4. Fabi SG. Noninvasive skin tightening: focus on new ultrasound techniques. Clin Cosmet Investig Dermatol. 2015;8:47-52. Published 2015 Feb 5. doi:10.2147/CCID.S69118